Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 4
2(28.6%)
7Total
N/A(5)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT04416724Not ApplicableRecruiting

Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma

Role: collaborator

NCT01166594Phase 4Completed

Use of Bevacizumab in Trabeculectomy Surgery

Role: collaborator

NCT03751059Phase 4Unknown

NSAID vs Steroid in Trabeculectomy Wound Management

Role: collaborator

NCT00940823Not ApplicableCompleted

The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma

Role: collaborator

NCT00485108Not ApplicableCompleted

Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

Role: collaborator

NCT00424996Completed

Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression

Role: collaborator

NCT00775489Not ApplicableCompleted

Nasal Steroids in Controlled Glaucoma

Role: collaborator

NCT00262626Not ApplicableTerminated

The Canadian Glaucoma Study

Role: collaborator

All 8 trials loaded